基于新抗原的个性化癌症疫苗的进展和挑战
Parminder Singh1,2, Mahalaqua Nazli Khatib3, Roopashree R4
1Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
基于新抗原的个性化癌症疫苗通过利用独特的遗传突变提供了精确的瘤向. 需要进一步的研究来改善新抗原的预测和传递,以提高有效性和更广泛的可访问性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 基于新抗原的个性化癌症疫苗代表了瘤学的重大进步.
- 这些疫苗针对独特的瘤特异性遗传变异,提高治疗的精度和有效性.
- 新抗原对于引导免疫系统对抗癌细胞而最大限度地减少副作用至关重要.
研究的目的:
- 审查基于新抗原的个性化癌症疫苗的进展.
- 检查这些疫苗在改变癌症治疗中的潜力.
- 讨论该领域的挑战和未来方向.
主要方法:
- 用于新抗原识别的基因组和蛋白质组技术.
- 生物信息学工具和预测模型用于新抗原选择.
- 创新的输送方法,包括脂质纳米粒子和病毒载体.
主要成果:
- 新抗原鉴定允许精确地绘制瘤突变景观.
- 由于瘤的可变性,预测免疫原性新抗原仍然存在挑战.
- 先进的输送系统对于提高疫苗稳定性和有效性至关重要.
结论:
- 基于新抗原的疫苗在癌症治疗中具有变革性的潜力.
- 预测模型和交付系统的持续改进至关重要.
- 这些疫苗符合可持续发展目标3.8,促进全民健康覆盖.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
10:18Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
